Live Science on MSN1d
CRISPR can treat common form of inherited blindness, early data hintIn a small trial, some people with inherited vision loss experienced improvements in their sight after being treated with ...
Q1 2024 Earnings Call Transcript May 14, 2024 Operator: Good morning, and welcome to Ocugen’s First Quarter 2024 Financial ...
At the same time, a study conducted in 2021-2023 using the CRISPR gene editing tool showed promising results — the technology ...
CRISPR gene-editing has improved the vision of patients with an inherited form of blindness, according to results of a Phase ...
Mass Eye and Ear-led phase 1/2 trial, which included 14 participants, found that the first-of-its-kind experimental treatment ...
Prevent Blindness Ohio designated May as “Inherited Retinal Disease (IRD) Genetic Testing Awareness Month,” expanding its previous IRD and Genetic Testing Awareness Week initiative.
Chip Chick on MSN1d
In A Groundbreaking Study, Researchers Tested A Novel Therapy Using CRISPR Gene Editing In Hopes Of Reversing Childhood Blindness Caused By LCATwo to three out of every 100,000 newborns are born with Leber congenital amaurosis (LCA), the most common cause of inherited ...
Conference Call and Webcast Today at 8:30 a.m. ETAll three first-in-class modifier gene therapy product candidates currently ...
A gene therapy trial at Cambridge University Hospitals in the UK has improved the hearing of an 18-month-old baby girl, born ...
Shankar Musunuri; Chairman of the Board, Chief Executive Officer; Ocugen Inc Michael Breininger; Principal Financial Officer, Interim Chief Accounting Officer; Ocugen Inc Arun Upadhyay; Chief ...
When an ophthalmologist assesses a patient with a history of a transient change in vision, the diagnosis of amaurosis fugax is the one most commonly considered. Amaurosis fugax is defined as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback